| Financial Year |
March 31 2023 |
| Monetary Funds |
9,126,265,412.22 |
| Held-for-trading Financial Assets |
2,060,927,535.67 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,943,637,934.66 |
| Advances to Suppliers |
14,638,671.85 |
| Other Receivables |
2,119,713,192.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
39,354,237,569.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,039,436,859.61 |
| Other Current Assets |
1,589,636,973.00 |
| Total Current Assets |
63,435,490,500.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
21,149,931.66 |
| Long-term Equity Investment |
5,826,501,400.85 |
| Investment Properties |
2,235,843,193.93 |
| Fixed Assetes |
524,874,538.07 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,178,638.87 |
| R&D expenses |
-- |
| Goodwill |
81,838,384.86 |
| Long-Term Deferred and Prepaid Expenses |
9,139,653.87 |
| Deferred Income Tax Assets |
892,494,552.86 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
22,036,848,763.41 |
| Total Assets |
85,472,339,263.95 |
| Short-Term Loans |
511,142,358.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
58,457,696.95 |
| Accounts Payable |
3,420,454,151.70 |
| Accounts Received In Advance |
9,336,020.26 |
| Employee Compensation Payable |
564,592,792.35 |
| Taxes Payable |
2,432,017,905.93 |
| Interest Payable |
-- |
| Dividend Payable |
731,383.20 |
| Other payables |
8,511,110,480.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,896,460,883.52 |
| Other Current Liabilities |
665,242,021.69 |
| Sub-Total of Current Liabilities |
36,194,453,717.87 |
| Long-term Loans |
9,854,051,999.55 |
| Bonds Payable |
9,688,559,920.06 |
| Long-Term Accounts Payable |
758,948,766.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
23,087,468.40 |
| Deferred Income Tax Liabilities |
221,073,857.63 |
| Other Non-Current Liabilities |
3,614,594,711.11 |
| Sub-Total of Non-Current Liabilities |
24,401,887,155.16 |
| Total Liabilities |
60,596,340,873.03 |
| Paid-In Capital(Or Share Stock) |
2,851,878,595.00 |
| Capital Surplus |
8,220,409,705.85 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,114,958,628.80 |
| Minority Stockholder's Interest |
688,751,461.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,187,246,929.65 |
| Owner's Equity（Stockholder's Equity） |
24,875,998,390.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
85,472,339,263.95 |
